Cancer Supportive Care Drugs Market: Granulocyte Colony Stimulating Factor (G-CSF) Segment Held The Largest Revenue Share

 Cancer Supportive Care Drugs Industry Overview

The global cancer supportive care drugs market size was valued at USD 14.03 billion in 2021 and is expected to decline with a compound annual growth rate (CAGR) of -1.57% from 2022 to 2030. The approval and uptake of targeted drugs, which have lesser side effects than traditional chemotherapy drugs, and the launch of biosimilars are expected to impede the market growth. Factors supporting the market include the rising prevalence of cancer, increase in the geriatric population, and high adoption of chemotherapy in low- and middle-income regions. The global COVID-19 pandemic has had a significant impact on cancer care. According to the American Society of Clinical Oncology, there was a substantial decline in visits, cancer screenings, surgeries, and therapy amid the pandemic.

In addition, hospital outpatient evaluation & management (E&M) visits (74%), new patient E&M visits (70%), and existing patient E&M visits (60%) all saw a significant decrease. However, in most regions, around the second quarter of 2021, the overall condition returned to normal. Rising cancer prevalence coupled with the increasing geriatric population is among the most prominent factors driving the market growth. According to Globocan, the number of new cancer cases is anticipated to reach 28.4 million within the next two decades, with a rise of 47% from 2020. Moreover, the geriatric population is more susceptible to cancer; in developing economies, life expectancy is now exceeding 80 years.

Gather more insights about the market drivers, restrains and growth of the Global Cancer Supportive Care Drugs market

According to the U.S. National Cancer Institute’s SEER Database, around two-thirds of all new cancer cases are diagnosed in people aged 65 years and above, showing that aging can make people more vulnerable to such disease. With the rise in technological advancements, major players are primarily focusing on the development of novel targeted therapies for the treatment of cancer. It has lesser adverse effects than traditional treatments, such as chemotherapy. These factors can impede the market growth over the forecast period. For instance, in April 2020, Gilead Sciences, Inc. received accelerated approval for Trodelvy (sacituzumab govitecan-hziy) from the U.S. FDA.

It is indicated for the treatment of patients with triple-negative breast cancer. It is an antibody-drug conjugate that targets and kills specific infectious cells through its toxic chemical molecule, hence having lesser side effects than chemotherapy and other traditional treatments. Furthermore, biosimilars and generic drugs gaining traction is another factor hampering the market growth. Companies are launching biosimilars of key drugs, impeding the growth of branded drugs. For instance, in June 2020, Pfizer received the approval for its NYVEPRIA, a biosimilar for Amgen’s NEULASTA.


Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

  • Bronchodilators Market - The global bronchodilators market size was estimated at USD 22.19 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.29% by 2030.
  • Postmenopausal Osteoporosis Treatment Market - Menopause is the most common cause of osteoporosis, and the world is witnessing rise in burden of disease in postmenopausal women which is the key factor driving the market.

Cancer Supportive Care Drugs Market Segmentation

Grand View Research has segmented the global cancer supportive care drugs market based on therapeutic class and region:

Cancer Supportive Care Drugs Therapeutic Class Outlook (Revenue, USD Million, 2017 - 2030)

  • G-CSFs (Granulocyte-colony Stimulating Factors)
  • ESAs (Erythropoiesis Stimulating Agents)
  • Anti-emetics
  • Bisphosphonates
  • Opioids
  • NSAIDs & Others

Cancer Supportive Care Drugs Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies profiled:
Some of the prominent companies operating in the global cancer supportive care drugs market include:

  • Amgen, Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Heron Therapeutics, Inc.
  • Novartis AG
  • GlaxoSmithKline plc (GSK)
  • Hoffmann-La Roche Ltd.
  • Helsinn Healthcare SA


Order a free sample PDF of the Cancer Supportive Care Drugs Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

 

Comments

Post a Comment

Popular posts from this blog

Global Composable Infrastructure Market Analysis Based On Component, End-Use, And Region

  Composable Infrastructure Industry Overview The global composable infrastructure market size was valued at USD 2,678.6 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 50.4% from 2022 to 2030. The increasing demand for efficient application performance and business analytics workload is expected to contribute to the growth of this market. Due to the outbreak of the COVID-19 pandemic, organizations have struggled to keep up with their regular infrastructure needs. Enterprises of all sizes have expanded rapidly, thus driving the demand for robust IT infrastructure. Countries have experienced intensified data demand during the pandemic and underscored the importance of data centers. Furthermore, during this period, composable infrastructures helped firms in virtualizing their entire Information Technology (IT) infrastructure by allowing them to adapt to flexible and adaptive infrastructure. These benefits of composable infrastructure during the pand
Read more

Insights into the Future: Analyzing the Endoscopy Devices Industry from 2023 to 2030

  Endoscopy Devices csIndustry Data Book | Forecast 2030 Endoscopy Devices Industry Data Book - Endoscopes, Endoscopy Visualization System, Endoscopy Visualization Component And Operative Devices Market Size, Share, Trends Analysis And Segment Forecasts, 2023 – 2030 Grand View Research’s endoscopy devices industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with an endoscopy devices statistics e-book.   Access the Global Endoscopy Devices Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental
Read more

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p
Read more